UC College of Medicine adds Department of Urology

Spectrum News highlights recent announcement

Spectrum News highlighted the recent announcement that the University of Cincinnati College of Medicine has established a new Department of Urology. It had been a division of the Department of Surgery since 1960.

The department will have six full-time faculty, 10 residents and seven advanced providers, and Ayman Mahdy, MD, PhD, sees potential for quick growth in the new department.

“It has a substantial opportunity for growth," said Mahdy, who has been chief of the Division of Urology since November 2019 and will serve as interim chair of the department. "Urology, being the third most common specialty catering to patients 65 years old and above, finds itself amidst a surge in the elderly sector and the baby boomer populations causing a substantial influx of patients."

With Alberto Martini, MD, starting in August as an assistant professor, the department will have six full-time faculty, 10 residents and seven advanced providers.

“It took a tremendous effort and support from the College of Medicine and Dean (Andrew) Filak, UC Physicians and Dr. Michael Archdeacon, and UC Health and Mr. Cory Shaw, to get this achieved,” Mahdy says. “Our faculty commitment to the tripartite mission and the support we received from Department of Surgery leadership of both Dr. Jeffrey Sussman and Dr. David Gerber were critical components of this achievement.”

Read the Spectrum News story.

Read more about the new Department of Urology.

Featured photo at top of the CARE/Crawley building. Photo/University of Cincinnati.

Related Stories

1

UC biologist talks about 'pearmageddon'

March 16, 2026

WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.